Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) Short Interest Update

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) was the target of a significant decline in short interest in January. As of January 15th, there was short interest totalling 200 shares, a decline of 66.7% from the December 31st total of 600 shares. Based on an average trading volume of 800 shares, the short-interest ratio is currently 0.3 days.

Mosaic ImmunoEngineering Price Performance

CPMV stock remained flat at $0.98 during midday trading on Wednesday. The company’s stock had a trading volume of 1 shares, compared to its average volume of 564. The business has a 50 day moving average price of $0.88 and a 200 day moving average price of $0.88. The company has a market capitalization of $7.09 million, a price-to-earnings ratio of -6.53 and a beta of 0.27. Mosaic ImmunoEngineering has a 1-year low of $0.10 and a 1-year high of $1.13.

Mosaic ImmunoEngineering Company Profile

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.